Phase I-II Study of Bendamustine in Patients With Acute Leukemia and High Risk Myelodysplastic Syndrome

Podobne zapisy

• A Phase II Study of Lenalidomide Alone in Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes With Chromosome 5 Abnormalities
  od: Chen, Yiming, i wsp.
  Wydane: (2012)
• Homoharringtonine with Imatinib in Chronic, Accelerated, and Blast Phase Chronic Myeloid Leukemia
  od: Maiti, Abhishek, i wsp.
  Wydane: (2017)
• Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin and Cytarabine in Patients with Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
  od: Assi, Rita, i wsp.
  Wydane: (2018)
• Phase I/II Trial of the Combination of Midostaurin (PKC412) and 5-Azacytidine for Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
  od: Strati, Paolo, i wsp.
  Wydane: (2015)
• Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome
  od: Dimicoli, Sophie, i wsp.
  Wydane: (2011)